Avidity Biosciences (RNA) had the highest return between June 10, 2024 and June 28, 2024 by a mid-cap US stock, returning 56.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Avidity Biosciences (RNA) | 6/10/2024 - 6/28/2024 | 56.21% |
Hut 8 Corp Common Stock (HUT) | 6/10/2024 - 6/28/2024 | 55.98% |
Terawulf (WULF) | 6/10/2024 - 6/28/2024 | 52.92% |
Enovix (ENVX) | 6/10/2024 - 6/28/2024 | 48.65% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 6/10/2024 - 6/28/2024 | 47.2% |
Nuscale Power (SMR) | 6/10/2024 - 6/28/2024 | 46.68% |
Ocular Therapeutix (OCUL) | 6/10/2024 - 6/28/2024 | 39.59% |
Mirum Pharmaceuticals (MIRM) | 6/10/2024 - 6/28/2024 | 39.15% |
Applied Digital (APLD) | 6/10/2024 - 6/28/2024 | 35.23% |
Arcutis Biotherapeutics (ARQT) | 6/10/2024 - 6/28/2024 | 30.62% |
RXO (RXO) | 6/10/2024 - 6/28/2024 | 30.29% |
Grindr (GRND) | 6/10/2024 - 6/28/2024 | 30.21% |
Cinemark (CNK) | 6/10/2024 - 6/28/2024 | 30.01% |
Six Flags Entertainment (FUN) | 6/10/2024 - 6/28/2024 | 29.41% |
Sarepta Therapeutics (SRPT) | 6/10/2024 - 6/28/2024 | 28.32% |
Amkor Technology (AMKR) | 6/10/2024 - 6/28/2024 | 23.52% |
Sprint Communications (S) | 6/10/2024 - 6/28/2024 | 23.17% |
Ionis Pharmaceuticals (IONS) | 6/10/2024 - 6/28/2024 | 22.36% |
AAON (AAON) | 6/10/2024 - 6/28/2024 | 22.27% |
LandBridge Company LLC (LB) | 6/10/2024 - 6/28/2024 | 21.84% |
Global-E Online (GLBE) | 6/10/2024 - 6/28/2024 | 21.18% |
ELF Beauty (ELF) | 6/10/2024 - 6/28/2024 | 20.97% |
Life360, Inc Common Stock (LIF) | 6/10/2024 - 6/28/2024 | 19.74% |
Verona Pharma PLC ADR (VRNA) | 6/10/2024 - 6/28/2024 | 19.01% |
BRF SA ADR (BRFS) | 6/10/2024 - 6/28/2024 | 19.01% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
